Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies

S Sebastian P. Fuchs P Paula G. Mondragon R Rachel Zabizhin S Shallu Tomer L Li Wang (The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou China) E Ethan Cook D Dawn M. Dudley K Kimberly L. Weisgrau J Jessica Furlott J Jennifer Coonen E Eric Alexander J Jun Xie (State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Natural Products, CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs) G Guangping Gao J James M. Termini J Jose M. Martinez-Navio A Anjie Zhen R Ronald C. Desrosiers

Article Details

Volume / Issue Vol. 16, Issue 1
Published October 07, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (17)

S

Sebastian P. Fuchs

P

Paula G. Mondragon

R

Rachel Zabizhin

S

Shallu Tomer

L

Li Wang

The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou China

E

Ethan Cook

D

Dawn M. Dudley

K

Kimberly L. Weisgrau

J

Jessica Furlott

J

Jennifer Coonen

E

Eric Alexander

J

Jun Xie

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Natural Products, CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs

G

Guangping Gao

J

James M. Termini

J

Jose M. Martinez-Navio

A

Anjie Zhen

R

Ronald C. Desrosiers